Treatment options for gastrointestinal bleeding blue rubber bleb nevus syndrome: Systematic review
Digestive Endoscopy · 2024
DOI: 10.1111/den.14564 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Digestive Endoscopy, 2024. Verfasst von Alessandro Rimondi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Nevus, Blue, Skin Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Blue rubber bleb nevus syndrome (BRBNS) is a rare challenging cause of gastrointestinal bleeding. We performed a systematic review of case reports and case series on BRBNS to gather information on the treatment options currently available.
Methods
All studies reporting a case of BRBNS in humans were evaluated. Papers were ruled out if CARE criteria and explanations on patient's selection, ascertainment, causality, and reporting were not respected or identified. PROSPERO 2021 CRD 42021286982.
Results
Blue rubber bleb nevus syndrome was treated in 106 cases from 76 reports. 57.5% of the population was under 18 years old, and up to 50% of the cases reported a previous treatment. Clinical success was achieved in 98 patients (92.4%). Three main types of interventions were identified: systemic drug therapy, endoscopy, and surgery. After BRBNS recurrence or previous therapy failure, systemic drug therapy emerged as a preferred second‐line treatment over endoscopy ( P = 0.01), but with a higher rate of reported adverse events when compared with surgery and endoscopy ( P < 0.001). Endoscopic treatment was associated with a higher number of required sessions to achieve complete eradication when compared with surgery ( P < 0.001). No differences between the three main areas were found in the overall follow‐up time ( P = 0.19) or in the recurrence rate ( P = 0.45).
Conclusion
Endoscopy, surgery, and systemic drug therapy are feasible treatment options for BRBNS. Systemic drug therapy was the favorite second‐line treatment after endoscopic failure or recurrence of BRBNS, but adverse events were more frequently reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
- Gastroenterology and Endoscopy Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Royal Free Unit for Endoscopy, The Royal Free Hospital and University College London Institute for Liver and Digestive Health, London, UK.
- Department of Gastroenterology, Cleveland Clinic London, London, UK.
ORCID-Profile: Alessandro Rimondi, Luca Elli
Zitieren
APA
Rimondi, A., Sorge, A., Murino, A., Nandi, N., Scaramella, L., Vecchi, M., Tontini, G. E., & Elli, L. (2024). Treatment options for gastrointestinal bleeding blue rubber bleb nevus syndrome: Systematic review. Digestive Endoscopy. https://doi.org/10.1111/den.14564
Vancouver
Rimondi A, Sorge A, Murino A, Nandi N, Scaramella L, Vecchi M, et al. Treatment options for gastrointestinal bleeding blue rubber bleb nevus syndrome: Systematic review. Digestive Endoscopy. 2024. doi:10.1111/den.14564
BibTeX
@article{Rimondi2024,
author = {Rimondi, Alessandro and Sorge, Andrea and Murino, Alberto and Nandi, Nicoletta and Scaramella, Lucia and Vecchi, Maurizio and Tontini, Gian Eugenio and Elli, Luca},
title = {Treatment options for gastrointestinal bleeding blue rubber bleb nevus syndrome: Systematic review},
journal = {Digestive Endoscopy},
year = {2024},
doi = {10.1111/den.14564}
}
EUVIMED